These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21363868)

  • 21. Cannabis and the increased incidence and persistence of psychosis.
    Hall W; Degenhardt L
    BMJ; 2011 Mar; 342():d719. PubMed ID: 21363867
    [No Abstract]   [Full Text] [Related]  

  • 22. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk.
    Konings M; Stefanis N; Kuepper R; de Graaf R; ten Have M; van Os J; Bakoula C; Henquet C
    Psychol Med; 2012 Jan; 42(1):149-59. PubMed ID: 21676285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cannabis use and the risk of psychotic disorders. An update].
    Kuepper R; van Winkel R; Henquet C
    Tijdschr Psychiatr; 2013; 55(11):867-72. PubMed ID: 24242146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosis and cannabis abuse in The Gambia. A case-control study.
    Rolfe M; Tang CM; Sabally S; Todd JE; Sam EB; Hatib N'Jie AB
    Br J Psychiatry; 1993 Dec; 163():798-801. PubMed ID: 8306122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use.
    Karcher NR; Barch DM; Demers CH; Baranger DAA; Heath AC; Lynskey MT; Agrawal A
    JAMA Psychiatry; 2019 Jan; 76(1):87-94. PubMed ID: 30347017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis use and psychosis: a longitudinal population-based study.
    van Os J; Bak M; Hanssen M; Bijl RV; de Graaf R; Verdoux H
    Am J Epidemiol; 2002 Aug; 156(4):319-27. PubMed ID: 12181101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence.
    Harley M; Kelleher I; Clarke M; Lynch F; Arseneault L; Connor D; Fitzpatrick C; Cannon M
    Psychol Med; 2010 Oct; 40(10):1627-34. PubMed ID: 19995476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    Br J Psychiatry; 2005 Dec; 187():510-5. PubMed ID: 16319402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
    Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of cannabis use in psychosis].
    Pajkossy P; Demetrovics Z
    Psychiatr Hung; 2007; 22(2):145-62. PubMed ID: 17895537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment.
    Spauwen J; Krabbendam L; Lieb R; Wittchen HU; van Os J
    Psychol Med; 2006 Mar; 36(3):407-15. PubMed ID: 16403242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.
    Andrade C
    J Clin Psychiatry; 2016 Jun; 77(6):e739-42. PubMed ID: 27337422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents.
    Perkonigg A; Lieb R; Höfler M; Schuster P; Sonntag H; Wittchen HU
    Addiction; 1999 Nov; 94(11):1663-78. PubMed ID: 10892006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychopathology and Pattern of Remission of Cannabis-Induced Psychotic Disorder.
    Suresh PN; Menon V; Suresh R; Uvais NA
    Prim Care Companion CNS Disord; 2023 Apr; 25(2):. PubMed ID: 37115153
    [No Abstract]   [Full Text] [Related]  

  • 37. The Relationship between Alcohol-Cannabis Use and Stressful Events with the Development of Incident Clinical Psychosis in a Community-Based Prospective Cohort.
    Kirli U; Binbay T; Alptekin K; Kayahan B; Elbi H
    Turk Psikiyatri Derg; 2021; 32(4):235-245. PubMed ID: 34964097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis use and expression of mania in the general population.
    Henquet C; Krabbendam L; de Graaf R; ten Have M; van Os J
    J Affect Disord; 2006 Oct; 95(1-3):103-10. PubMed ID: 16793142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cannabis and psychosis--a review].
    Schaub M; Rössler W; Stohler R
    Praxis (Bern 1994); 2004 Jun; 93(23):997-1002. PubMed ID: 15233568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.